# Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)

> **NCT03435120** · — · COMPLETED · sponsor: **Angelini Farmacéutica** · enrollment: 118 (actual)

## Conditions studied

- Breakthrough Pain

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03435120
- **Lead sponsor:** Angelini Farmacéutica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-21
- **Primary completion:** 2020-01-24
- **Final completion:** 2020-02-14
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03435120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03435120, "Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03435120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*